Personality profile and therapeutic response to lithium carbonate and sodium valproate in mania with psychotic features

Int Clin Psychopharmacol. 2022 Mar 1;37(2):54-59. doi: 10.1097/YIC.0000000000000385.

Abstract

Bipolar disorder is one of the major psychiatric disorders. Therefore, determining the factors that predict mood stabilizer response is important. This study aimed to investigate the relationship between personality profile and the response to lithium carbonate and sodium valproate in patients with psychotic mania. In this study, 50 patients with bipolar I disorder (manic episode with psychotic features) were randomly assigned to receive lithium carbonate (up to a serum level of 0.8-1.5 mEq/L) or sodium valproate (20 mg/kg). After stabilization of acute manic phase, Temperament and Character Inventory was completed by the patients themselves. Fifty subjects completed this study. The mean age ± SD of participants in the sodium valproate group and lithium carbonate group was 32.99 ± 9.94 and 30.73±7.94 years, respectively. The responders to sodium valproate had significantly higher scores in novelty seeking, harm avoidance (P = 0.003 and 0.004, respectively) and lower scores in persistence (P = 0.006) than the non-responders, but the responders to lithium carbonate did not have significantly different personality profiles. The results of the present study revealed that the personality profiles in the inpatients with psychotic mania are related to the responses to sodium valproate, but are irrelevant to the responses to lithium carbonate.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Antimanic Agents / therapeutic use
  • Humans
  • Lithium
  • Lithium Carbonate* / therapeutic use
  • Mania
  • Personality
  • Valproic Acid* / therapeutic use

Substances

  • Antimanic Agents
  • Lithium Carbonate
  • Valproic Acid
  • Lithium